Abstract
Background Nepal has achieved and sustained elimination of leprosy as a public health problem since 2009, but 17 districts and 3 provinces have yet to eliminate the disease. Pediatric cases and grade-2 disabilities (G2D) indicate recent transmission and late diagnosis respectively, which necessitate active and early case detection. This operational research was performed to identify approaches best suited for early case detection, determine community-based leprosy epidemiology, and identify hidden leprosy cases early and respond with prompt treatment.
Methods Active case detection was performed by: house-to-house visits among vulnerable populations (n=26,469), contact examination and tracing (n=7,608) and screening prison populations (n=4,428) in Siraha, Bardiya, Rautahat, Banke, Lalitpur and Kathmandu districts of Nepal.
Results New case detection rates were highest for contact tracing (250), followed by house-to-house visits (102) and prison screening (45) per 100,000 population screened. However, cost per case identified was cheapest for house-to-house visits (Nepalese rupee (NPR) 76,500/case), then contact tracing (NPR90,286/case) and prison screening (NPR298,300/case). House-to-house and contact tracing case paucibacillary/multibacillary (PB:MB) ratios were 59:41 and 68:32; female/male ratios 63:37 and 57:43; pediatric cases 11% in both approaches; and G2D 11% and 5% respectively. Developing leprosy was similar among household and neighbor contacts (Odds ratios (OR)=1.4, 95% confidence interval (CI), 0.24-5.85) and for contacts of MB versus PB cases (OR=0.7, 0.26-2.0). Attack rates were similar among household contacts of MB cases (0.32%, 0.07-0.94%) and PB cases (0.13%, 0.03-0.73) and neighbor contacts of MB cases (0.23%, 0.1-0.46) and PB cases (0.48%, 0.19-0.98). BCG vaccination with scar presence had a significant protective effect against leprosy (OR=0.42, 0.22-0.81).
Conclusions The most effective case identification approach here is contact tracing, followed by house-to-house visits in vulnerable populations and screening in prisons, though house-to-house visits were cheaper. The findings suggest hidden cases, recent transmission, and late diagnosis in the community exist and highlight the importance of early case detection.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this study. The study was the regular surveillance activity.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study has been approved by the Ethical Review Board of Nepal Health Research Council (approval number 347/2022 P
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Two authors were added in the newer version. minor changes in the introduction and in the statistical analysis part done.
Data availability
The datasets generated and/or analyzed during the current study are not publicly available due to individual privacy of patients could be compromised but are available from the corresponding author on reasonable request.
Abbreviations
- BCG
- Bacille Calmette-Guerin
- CI
- Confidence Interval
- EDCD
- Epidemiology and Disease Control Division
- FCHV
- Female Community Volunteer
- G2D
- Grade-2 disabilities
- LCDMS
- Leprosy Control and Disability Management Section
- LPEP
- Leprosy post exposure prophylaxis
- MB
- Multibacillary
- NPR
- Nepalese rupee
- OR
- Odds ratios
- PB
- Paucibacillary
- SEAR
- South-East Asia Region
- SPSS
- Statistical Package for the Social Sciences
- WHO
- World Health Organization
